Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 72 (TRIM72, also called MG53) is a muscle-specific E3 ubiquitin ligase prominently involved in membrane repair by nucleating the assembly of the repair machinery at sites of plasma membrane injury[1][2][3][8]. It consists of a RING domain, B-box, coiled-coil, and C-terminal SPRY domain characteristic of the TRIM protein family[3]. TRIM72 is primarily expressed in striated muscle and the heart but is also found in smaller amounts in other tissues such as kidney, lung, and cornea[3]. Functional studies indicate that TRIM72 protects tissues during acute injury and ischemia, participates in innate immune signaling, influences metabolic regulation (including insulin resistance), and has been proposed to exert anti-tumor effects via its ligase activity[1][3]. Its role in rapidly promoting the repair of sarcolemmal and plasma membrane lesions makes it a candidate therapeutic target in muscle degenerative diseases and acute tissue injuries. Experimental therapies using recombinant MG53 are in development, but no approved drugs currently target TRIM72 directly[3].
Stimulating membrane repair through recruitment of vesicles to the membrane injury site; mediating ubiquitination of target proteins; scaffolding to recruit repair machinery; modulating intracellular signaling and immune responses
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 72 (TRIM72 (also known as MG53)).